The odds a heart patient will experience complications after they’re implanted with a cardiac device vary depending on where they receive care, according to work published in the Annals of Internal Medicine July 30.
A study published in JAMA Cardiology July 24 suggests high-intensity statin use after MI depends on where patients live in the U.S., with 66% higher use in New England than in the country’s West South Central region.
The Cleveland Clinic in Cleveland, Ohio, topped this year’s U.S. News & World Report’s list of the best hospitals for cardiology and heart surgery in the country, published at the end of July.
Sixty-nine people have survived out-of-hospital cardiac arrests at Hawaii’s airports since an AED program was first implemented in 2006, the Oregonian reports.
Chris Semsarian, PhD, MPH, has been announced as the newest editor-in-chief of the American Heart Association’s journal Circulation: Genomic and Precision Medicine.
Swiss drugmaker Novartis on July 29 announced its combo sacubitril/valsartan drug Entresto “narrowly missed” its primary endpoint in the Phase III PARAGON-HF study, throwing into question the future of a blockbuster drug.
Medications used to treat atrial fibrillation—namely amiodarone—could increase older patients’ risk of fainting and falling, Danish researchers have found.
A handful of hospitals in the Texas panhandle are creating a telemedicine network that extends specialist care—including cardiology—to patients in more rural areas of the state.
Maquet and Datascope issued a nationwide recall of 22,853 intra-aortic balloon pumps July 23 following reports of five patient deaths and numerous battery failures.
A study that aimed to characterize cardiac ICU care patterns and outcomes in North America has identified respiratory failure and shock as the predominant reasons for CICU admission—and, despite high resource use, outcomes for many patients were poor.
